Treatment of Latent TB Infection (LTBI)

 

Video iconVideoTranscript       List of Reviewers

Additional Resources

Latent Tuberculosis Infection: A Guide for Primary Health Care Providers- Booklet
Centers for Disease Control and Prevention

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (& Updates) - Guidelines
Centers for Disease Control and Prevention

Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States – 2010 Guidelines
Centers for Disease Control and Prevention

Core Curriculum on Tuberculosis: What the Clinician Should KnowCME material
Centers for Disease Control and Prevention

TB 101 for Health Care Workers– Online course
Centers for Disease Control and Prevention

Diagnosis and Treatment of Latent Tuberculosis Infection- Pocket Card
NJMS Global Tuberculosis Institute

Management for Latent Tuberculosis Infection in Children and Adolescents: A Guide for the Primary Care Provider - Booklet
New Jersey Medical School Global Tuberculosis Institute

Reccomendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection - Guidelines
Centers for Disease Control and Prevention

Tuberculosis Drug Information Guide-2nd edition- Booklet
Curry International Tuberculosis Center

Tuberculosis Medication Food and Drug Interactions- Pocket card
Heartland National TB Center

Assessing and Managing the Risk of Liver Disease in the Treatment of LTBI - Algorithm
Heartland National TB Center

Resources for Patients

What You Need to Know About Your Medicine for Latent Tuberculosis (TB) Infection– Factsheet Series
Centers for Disease Control and Prevention
Isoniazid
Rifampin
Isonizid and Rifapentine